SARS-CoV-2 Spike Glycoprotein Antibody (FITC)

REQUEST MORE INFO
Catalogue No: abx243128
Price: US$333.50
(Size: 50 µl)

Click on the image to see the image legend

Available Options

* Size:


Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Glycoprotein Antibody is a chimaeric recombinant antibody conjugated to FITC for the detection of SARS-CoV-2/COVID-19 S Protein. This antibody is expressed in HEK293 cells and contains Mouse scFv and C-terminal Human IgG1 Fc tag.

The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.

Target Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Glycoprotein
Clonality Monoclonal
Reactivity Virus
Origin Human
Expression Recombinant
Tested Applications ELISA
Host Human, Mouse
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation FITC
Immunogen Recombinant SARS-CoV-2 S protein (16-685 AA) expressed in Mammalian cells
Isotype IgG1
Form Liquid
Purification Purified by affinity chromatography.
Storage Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC P0DTC2 (UniProt, ExPASy)
GeneID 43740568
Buffer 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol.
Concentration 0.25 mg/ml
Availability Shipped within 5-10 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Glycoprotein